Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice

Endocrinology

Volumn 148, Issue 6, 2007, Pages 2845-2853

  Wang, Zhihui ^a,b   Masternak, Michal M ^a   Al Regaiey, Khalid A ^c   Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; ENZYME; FATTY ACID; GROWTH HORMONE; INTERLEUKIN 6; LIPID; MESSENGER RNA; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CELL DIFFERENTIATION; CELL STRUCTURE; CHOLESTEROL BLOOD LEVEL; FEMALE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER; MALE; METABOLITE; MOUSE; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; REGULATORY MECHANISM; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ANIMALS; BODY WEIGHT; CALORIC RESTRICTION; CYTOKINES; GROWTH HORMONE; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PHENOTYPE;

EID: 34250884797     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1313     Document Type: Article

References (50)

1. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R 2003 Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111-1117
2. Lochhead PA, Salt IP, Walker KS, Hardic DG, Sutherland C 2000 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49:896-903
3. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
4. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
5. Roger HU 2003 Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159-5165
6. Shuldiner AR, Yang R, Gong D-W 2001 Resistin, obesity, and insulin resistance - the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345:1345-1346
7. Meier U, Gressner AM 2004 Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50:1511-1525
8. Kimb KH, Lee K, Moon YS, Sul HS 2001 A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
9. Rajala MW, Obici S, Scherer PE, Rossetti L 2003 Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 111:225-230
10. Hotamisligil GS, Spiegelman BM 1994 Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278
11. Greenberg AS, McDaniel ML 2002 Identifying the links between obesity, insulin resistance and β-cell function: potential role of adipocyte derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32(Suppl 3):24-34
12. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA 2003 Suppressor of cytokine signaling-3: a potential mediator of interleukin-6 dependent insulin resistance in hepatocytes. J Biol Chem 278:13740-13746
13. Boden G, Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14-23
14. Fasshauer M, Kralisch S, Klier M 2003 Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3 - L1 adipocytes. Biochem Biophys Res Commun 301:1045-1050
15. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
16. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD 1997 The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196
17. Garg A, Misra A 2004 Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clinic North Am 33:305-331
18. Yaney GC, Corkey BE 2003 Fatty acid metabolism and insulin secretion in pancreatic β cells. Diabetologia 46:1297-1312
19. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
20. Dominici FP, Cifone D, Bartke A, Turyn D 1999 Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. Endocrinol 161:383-392
21. Dominici FP, Cifone D, Bartke A, Turyn D 1999 Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am J Physiol Endocrinol Metab 277:E447-E454
22. Valera A, Rodriguez-Gil JE, Yun JS, McGrane MM, Hanson RW, Bosch F 1993 Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone. FASEB J 7:791-800
23. Balbis A, Bartke A, Turyn D 1996 Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci 59:1363-1371
24. Shea BT, Hammer RE, Brinster RL 1987 Growth allometry of the organs in giant transgenic mice. Endocrinology 121:1924-1930
25. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ 2004 Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res 14:309-318
26. Weindruch R, Sohal RS 1997 Caloric intake and aging. N Engl J Med 337:986-994
27. Dean DJ, Gazdag AC, Wetter TJ, Cartee GD 1998 Comparison of the effects of 20 days and 15 months of caloric restriction on male Fischer 344 rats. Aging 10:303-307
28. Walford RL, Mock D, Verdery R, MacCallum T 2002 Caloric restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol Biol Sci 57A:B211-B224
29. Cartee GD, Dean DJ 1994 Glucose transport with brief dietary restriction: heterogenous responses in muscles. Am J Physiol 266:E946-E952
30. Kemnitz JW, Roecker EB, Weindruch R, Elson DF, Baum ST, Bergman RN 1994 Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol 266:E540-E547
31. Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, Caro JF 1992 Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect of muscle glucose transport and glucose transporter GLUT4. J Clin Invest 89:701-705
32. McGrane MM, de Vente J, Yun J, Bloom J, Park E, Wynshaw-Boris A, Wagner T, Rottman FM, Hanson RW 1988 Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J Biol Chem 263:11443-11451
33. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
34. Masternak MM, Al-Regaiey KA, Del Rosario Lim MM, Bonkowski MS, Panici JA, Przybylski GK, Bartke A 2005 Caloric restriction results in decreased expression of peroxisome proliferator-activated receptors (PPARs) superfamily in muscle of normal and long-lived GHR-KO mice. J Gerontol Biol Sci Med Sci 60A:1238-1245
35. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A 2005 Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor I/insulin signaling and caloric restriction. Endocrinology 146:851-860
36. Faraj M, Havel PJ, Phelis S, Blanck D, Snideman AD, Cianflone K 2003 Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594-1602
37. Beck P, Schalch DS, Parker ML, Kipnis DM, Daughaday WH 1965 Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med 66:366-374
38. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R 1986 Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273
39. Rizza RA, Mandarino LJ, Gerich JE 1982 Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669
40. Ng SF, Storlien LH, Kraegen EW, Stuart MC, Chapman GE, Lazarus L 1990 Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo. Metabolism 39:264-268
41. Wang ZH, Al-Regaiey KA, Masternak MM, Bartke A 2006 Adipocytokines and lipid levels in Ames Dwarf and caloric restricted mice. J Gerontol A Biol Sci Med Sci 61:323-331
42. Nilsson L, Binart N, Bohlooly-Y M, Bramnert M, Egecioglu E, Kindblom J, Kelly PA, Kopchick JJ, Ormandy CJ, Ling C, Billig H 2005 Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 331:1120-1126
43. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC, Tam S 2004 Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab 89:5448-5453
44. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
45. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA 2004 Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206
46. Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, Reitman ML 2002 WY14,643, a peroxisome proliferator-activated receptor α (PPARα) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J Biol Chem 277:24484-24489
47. Samuel VT, Liu Z, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI 2004 Mechanism of hepatic insulin resistance in non-alcoholic fatty liver Disease. J Biol Chem 279:32345-32353
48. Voshol PJ, Haemmerle G, Ouwens DM, Zimmermann R, Zechner R, Teusink B, Maassen JA, Havekes LM, Romijn JA 2003 Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144:3456-3462
49. Barbour LA, Rahman SM, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, LeRoith D, Kahn CR, Cantley LC, Friedman JE, Draznin B 2005 Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 280:37489-37494
50. Miquet JG, Sotelo AI, Bartke A, Turyn D 2004 Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 145:2824-2832